Manchester and Dundee, UK, 07 November 2018: Concept Life Sciences (“Concept”), the integrated drug discovery and development and analytical services company, today announced the expansion of its regulatory GLP (good laboratory practice) capabilities at the Group’s Dundee and Bradford sites. The MHRA has confirmed the extension of Dundee’s in-vitro capabilities to cover a range of additional assays, and Bradford can now offer a range of GLP regulatory studies in the physical and chemical testing fields.
The GLP accreditations allows scientists based at Concept’s Bradford site to perform integrated studies in conjunction with the Dundee site’s wide range of in vitro assays, providing enhanced services to customers in the agrochemical, biocide and chemical fields, and also supporting pharmaceuticals, medical devices and healthcare. The extension forms part of a phased plan to expand GXP compliance (including GLP and GMP) at Concept’s facilities across the UK.
The breadth of services offered to customers at all stages of discovery and development now also covers compounds going through re-registration. In addition to its original non-regulatory services, the Company’s regulatory offering now includes a wide range of assays for enzyme activity, microsomal inhibition, metabolite identification, and cell culture, including hepatocyte induction studies.
The accreditation also enables Concept to offer a range of regulatory and product registration studies to customers in the physical and chemical testing fields, including Independent Laboratory Validation, REACH registration, Biocidal Products registration, GLP stability studies and key GLP product registration tests, such as five batch analysis.
John Handley, Chief Operating Officer, Concept Life Sciences, said: “The extension of our GLP accreditation by the MHRA in both Dundee and Bradford enables us to further expand the growing portfolio of services we offer to our clients. The accreditations reflect Concept’s ongoing strategy to implement GXP compliance across multiple sites, and to grow as a company.”